Dr. Cédric Cheminay

Biography

Dr. Cédric Cheminay obtained a PhD in Immunology at the Friedrich-Alexander-University of Erlangen-Nürnberg, Germany. During his academic career at the Pasteur Institute of Lille, FAU and Ludwig-Maximilian-University, he focused his research on the interactions of pathogens, bacteria and different vaccine platforms with the immune system, especially dendritic cells. In 2007, he joined Bavarian Nordic and participated in research activities and preclinical development of MVA-BN and several poxvirus-based vaccines (e.g. RSV, HIV, Filoviruses). Since 2016, he is responsible of the VSV-GP pre-clinical development program at ViraTherapeutics.

Research Interest

pathogens, bacteria and different vaccine platforms with the immune system, especially dendritic cells